Investigating depression in multiple sclerosis: an Italian Delphi consensus on clinical manifestations, diagnosis and treatment
BackgroundIn multiple sclerosis (MS), depression represents one of the most frequent psychiatric comorbidities, significantly impacting patients’ quality of life and disease progression. However, the diagnosis and management of depression in MS remain challenging due to overlapping symptoms and the...
Saved in:
| Main Authors: | Antonio Bruno, Ettore Dolcetti, Pietro Annovazzi, Marinella Clerico, Eleonora Cocco, Antonella Conte, Girolama Alessandra Marfia, Marco Salvetti, Valentina Tomassini, Valentina Torri Clerici, Rocco Totaro, Ferdinando Nicoletti, Diego Centonze |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Psychiatry |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2025.1557335/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Choosing initial MS therapy; personal, disease, and medication factors
by: Bruce A. Cohen
Published: (2025-07-01) -
Ageing and multiple sclerosis
by: Julija Isačenko, et al.
Published: (2024-12-01) -
Is it possible to discontinue glucocorticoids in rheumatoid arthritis with the use of synthetic disease-modifying antirheumatic drugs?
by: O. B. Iaremenko, et al.
Published: (2023-07-01) -
Adherence to disease modifying therapies in patients with multiple sclerosis
by: D. Pileckė, et al.
Published: (2019-06-01) -
EFFICACY AND SAFETY OF SIMVASTATIN IN RHEUMATOID ARTHRITIS: AN OPEN-LABEL, CONTROLLED STUDY
by: I. V. Shirinsky, et al.
Published: (2014-07-01)